Skip to content

GEMI GEMI Impairment of long-lived assets

Impairment of long-lived assets at other companies

Alto Ingredients, Inc. logo
Alto Ingredients, Inc.ALTO
$200.75K-96.8%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$0
UBS
United BanksharesUBSI
$13.75K-74.9%
APO
Apogee EnterprisesAPOG
$4.06M-46.8%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$0-100%
Encore Capital Group logo
Encore Capital GroupECPG
$0-100%

Other financials

Income statement

See full
Revenue$50.3M+42.3%
Operating income-$94.2M-96.1%
Net income-$109.0M+27.0%
EPS (diluted)-$0.93+96.9%

Balance sheet

See full
Cash & equivalents$803.1M+39.1%
Total debt$25.7M
Total equity$456.1M+149%
Total assets$1.5B

Cash flow

See full
Operating cash flow-$54.4M-196%
CapEx$127.0K-32.4%
Free cash flow-$54.6M-193%

Valuation

See full
Market cap$494.35M-87.2%
Enterprise value-$283.08M
P/S2.5×

Profitability

See full
Operating margin-201.4%
Net margin-278.9%
FCF margin-212%

Returns & leverage

See full
Return on equity225%
Debt / equity0.1×
Current ratio1.3×

Where this comes from

Reported directly by GEMI in its filing.

Tagged under the XBRL concept us-gaap:TangibleAssetImpairmentCharges.

The official record: GEMI’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about GEMI's impairment of long-lived assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GEMI's impairment of long-lived assets?
GEMI (GEMI) reported impairment of long-lived assets of $1.33M in Q1 2026.
What does impairment of long-lived assets mean?
Represents the non-cash charge recognized when the carrying amount of long-lived tangible assets exceeds their recoverable value. This metric reflects the loss in economic utility of physical assets and serves as an indicator of asset quality and management's capital expenditure efficiency.